A 29-year-old Chilean man is seeking 101.5m pesos after alleging that a faulty NovoRapid FlexPen failed to deliver his insulin and triggered a severe hyperglycaemic episode. A Chilean patient has filed a lawsuit against Novo Nordisk, accusing the company of…
CGM readings can add context to weight-management care, but patients must confirm how their clinic wants the data shared, reviewed and acted on. A continuous glucose monitor can add useful context to a medical weight-loss programme, but it does not…
Argentine doctor Jorge Tartaglione explains the fasting, post-meal and HbA1c readings that should prompt lifestyle changes and medical follow-up. Keeping blood glucose under control is central to metabolic health, and Argentine doctor Jorge Tartaglione used a recent appearance on LN+…
Leonard Thompson’s successful insulin treatment in Toronto in January 1922 transformed type 1 diabetes from a rapidly fatal disease into a manageable chronic condition. For much of medical history, a diagnosis of type 1 diabetes was often a death sentence.…
A breakthrough in Toronto in 1922 transformed type 1 diabetes from an often fatal diagnosis into a condition that could be managed, after James Collip helped purify the treatment for human use. By 1922, a breakthrough in Toronto had begun…
A purified insulin treatment given to 14-year-old Leonard Thompson in Toronto in January 1922 marked the breakthrough that transformed Type 1 diabetes from a fatal disease into a manageable condition. Insulin’s discovery in the early 1920s transformed diabetes from a…
The latest 6FPS newsletter weighs Apple’s subscription push and design reshuffle alongside a USENET time capsule, a failed two-watch experiment and a much-needed home network upgrade. The latest issue of Chuq Von Rospach’s 6FPS newsletter moves easily between the practical…
A reflective newsletter spans retro internet archaeology, Apple’s subscription push, home-network upgrades and the practical habits behind lasting health improvements. In his February 9, 2026, newsletter, Chuq Von Rospach describes a month that feels both seasonal and personal: the days…
A software fault in Nova Biomedical’s StatStrip Gen 2.0 meters may attach a valid glucose reading to the wrong patient, prompting the FDA to classify the recall as Class I. The Food and Drug Administration said on Monday that Nova…
Doctors may consider anti-obesity medicines sooner than many patients expect, but side effects, long-term use and high costs remain significant barriers. Obesity remains a major long-term health problem, and the World Health Organization says the global burden has continued to…
